Super-speedy cancer drug reviews: FDA unveils new draft guidance to help sponsors apply

endpts.com - How does a cancer drug cross the FDA finish line 3-5 months before its PDUFA date? That's where the Real-Time Oncology Review comes in. For the last five years, FDA's Oncology Center of Excellence un… Tweeted by @_timos_ https://twitter.com/_timos_/status/1550552448388849664
https://bit.ly/3RWItrK